Munich - Delayed Quote EUR
Oryzon Genomics SA (ORN.MU)
2.5400
+0.1600
+(6.72%)
As of 8:03:39 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-574.9610
-1,847.5790
-3,626.4200
-4,817.2760
Investing Cash Flow
--
-14,503.5530
-14,271.3280
-11,724.1790
-9,081.5360
Financing Cash Flow
--
6,021.1670
8,709.9670
4,122.7990
18,381.5020
End Cash Position
--
12,256.9120
21,316.8840
28,724.7380
39,604.8880
Capital Expenditure
--
-14,502.6000
-14,270.6760
-11,761.1960
-9,223.0920
Issuance of Capital Stock
--
--
--
--
22,084.3673
Issuance of Debt
--
15,514.5400
14,068.4890
7,960.1510
7,066.6730
Repayment of Debt
--
-7,613.8170
-4,426.2550
-3,837.3520
-6,866.1780
Free Cash Flow
--
-15,077.5610
-16,118.2550
-15,387.6160
-14,040.3680
12/31/2020 - 3/24/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
REVBW Revelation Biosciences, Inc.
0.0157
+4.67%
EGTX.ST Egetis Therapeutics AB (publ)
3.8850
-1.40%
PHM.MC Pharma Mar, S.A.
81.40
+0.74%
NAMS NewAmsterdam Pharma Company N.V.
17.17
-0.58%
CELZ Creative Medical Technology Holdings, Inc.
1.9965
+1.35%
REVB Revelation Biosciences, Inc.
2.9000
+2.47%
ACIU AC Immune SA
1.5950
+0.95%
MBRX Moleculin Biotech, Inc.
1.0947
+6.21%
SWTX SpringWorks Therapeutics, Inc.
41.32
+0.27%
CADL Candel Therapeutics, Inc.
5.04
+5.88%